Cigna invests $100M in AI pharmacy program amid specialty drug boom

Cigna's Evernorth is investing $100 million into a new AI-powered pharmacy program, "Pharmacy Forward," aimed at improving clinical care and patient outcomes. This investment is part of a broader trend of significant capital flowing into the specialty pharmacy sector, driven by the high cost and growth of specialized medications like GLP-1s for obesity. Private equity firms are also actively acquiring specialty pharmacy businesses, with Peak Rock Capital recently purchasing Asembia, a company that provides distribution and technology services for the sector. AI

IMPACT Accelerates AI integration in healthcare services, potentially improving patient outcomes and operational efficiency in specialty pharmacy.

RANK_REASON Significant investment in an AI-powered healthcare program by a major insurer, reflecting broader industry trends in specialty pharmacy. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Forbes — Innovation →

• Accredo
• Asembia
• CVS Health
• Elevance Health
• Evernorth
• Express Scripts
• GLP-1
• Humana
• Peak Rock Capital
• Pharmacy Forward
• Sycamore Partners
• Cigna
• UnitedHealth Group

• funding
• product
• infra

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →